Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Federal Trade Commission
QuintilesIMS
Argus Health
Cipla
Johnson and Johnson
Julphar
Boehringer Ingelheim
Dow

Generated: October 23, 2017

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide; reserpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of hydralazine hydrochloride; hydrochlorothiazide; reserpine patent protection?

Hydralazine hydrochloride; hydrochlorothiazide; reserpine
is the generic ingredient in twelve branded drugs marketed by Lederle, Solvay, Watson Labs, Sun Pharm Inds, Sandoz, Ivax Sub Teva Pharms, Mylan, Novartis, and Tg United Labs, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; hydrochlorothiazide; reserpine.

Summary for Generic Name: hydralazine hydrochloride; hydrochlorothiazide; reserpine

US Patents:0
Tradenames:12
Applicants:9
NDAs:16
Drug Master File Entries: see list20
Clinical Trials: see list2,639
Drug Prices:see low prices
DailyMed Link:hydralazine hydrochloride; hydrochlorothiazide; reserpine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL085771-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL085549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL087085-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
HYDRAP-ES
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL084876-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Tg United Labs
CAM-AP-ES
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL084897-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL083770-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
SER-AP-ES
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL012193-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL087556-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
UNIPRES
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL085893-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
SER-A-GEN
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL087210-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Teva
Cipla
Novartis
McKesson
Moodys
Mallinckrodt
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot